These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21498534)

  • 61. Changes in the pulmonary function test after radioactive iodine treatment in patients with pulmonary metastases of differentiated thyroid cancer.
    Jang EK; Kim WG; Kim HC; Huh JW; Kwon H; Choi YM; Jeon MJ; Kim TY; Shong YK; Ryu JS; Kim WB
    PLoS One; 2015; 10(4):e0125114. PubMed ID: 25923702
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of locally invasive carcinoma of the thyroid: how radical?
    Breaux GP; Guillamondegui OM
    Am J Surg; 1980 Oct; 140(4):514-7. PubMed ID: 7425234
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differentiated thyroid cancer: outcome of treatment in 80 cases.
    Sethi VK
    Ann Acad Med Singap; 1990 Jul; 19(4):435-8. PubMed ID: 2221797
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ablation in differentiated thyroid carcinoma: how much surgery? How much iodine?
    al-Nahhas AM
    Nucl Med Commun; 1999 Jul; 20(7):595-7. PubMed ID: 10423760
    [No Abstract]   [Full Text] [Related]  

  • 65. Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade.
    Verburg FA; Flux G; Giovanella L; van Nostrand D; Muylle K; Luster M
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):78-83. PubMed ID: 31616967
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prescribed Activity of
    Van Nostrand D
    J Nucl Med; 2017 May; 58(5):697-699. PubMed ID: 28209908
    [No Abstract]   [Full Text] [Related]  

  • 67. Thyroid cancer in 2013: Advances in our understanding of differentiated thyroid cancer.
    Reiners C
    Nat Rev Endocrinol; 2014 Feb; 10(2):69-70. PubMed ID: 24296516
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential distribution and prognostic value of CD4
    Shi ZY; Zhang SX; Li CH; Fan D; Xue Y; Cheng ZH; Wu LX; Lu KY; Wu ZF; Li XF; Liu HY; Li SJ
    Front Immunol; 2022; 13():966550. PubMed ID: 36091039
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel concepts for initiating multitargeted kinase inhibitors in radioactive iodine refractory differentiated thyroid cancer.
    Tuttle RM; Brose MS; Grande E; Kim SW; Tahara M; Sabra MM
    Best Pract Res Clin Endocrinol Metab; 2017 Jun; 31(3):295-305. PubMed ID: 28911726
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy.
    Tulchinsky M; Binse I; Campennì A; Dizdarevic S; Giovanella L; Jong I; Kairemo K; Kim CK
    J Nucl Med; 2018 May; 59(5):723-725. PubMed ID: 29653977
    [No Abstract]   [Full Text] [Related]  

  • 71. [Endoscopic observation of thyroid carcinoma successfully treated with radioactive Iodine (131I) (author's transl)].
    Kobayashi M; Sugenoya A; Miyakawa M; Makiuchi M
    Kaku Igaku; 1981 Nov; 18(9):1301-4. PubMed ID: 7339104
    [No Abstract]   [Full Text] [Related]  

  • 72. Evaluation of the quality of life in patients followed for differentiated cancer of the thyroid.
    Haraj NE; Bouri H; El Aziz S; Nani S; Habti N; Chadli A
    Ann Endocrinol (Paris); 2019 Feb; 80(1):26-31. PubMed ID: 29571888
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quality of life-in patients with differentiated thyroid cancer at the general endocrinology clinics of the University Hospital of Puerto Rico.
    Vega-Vázquez MA; Gonzalez-Rodriguez L; Santiago-Rodríguez EJ; Garcés-Domínguez A; Shum LM; Tírado-Gómez M; Ramírez-Vick M
    Bol Asoc Med P R; 2015; 107(1):25-31. PubMed ID: 26035981
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of Dosimetrically Guided I-131 Therapy on Hematopoiesis in Patients With Differentiated Thyroid Cancer.
    Bikas A; Schneider M; Desale S; Atkins F; Mete M; Burman KD; Wartofsky L; Van Nostrand D
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1762-9. PubMed ID: 26900639
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thyroid carcinoma in two patients with ataxia-telangiectasia: Tailored diagnostic and therapeutic use of radioiodine.
    Rivalta B; Giancotta C; Leone F; D'Aniello F; Vergani E; Profeti E; Pacillo L; Rossi ED; Locantore P; Pontecorvi A; Garganese MC; Grossi A; Ubertini G; Cancrini C; Palma P; Finocchi A
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30535. PubMed ID: 37391869
    [No Abstract]   [Full Text] [Related]  

  • 76. Outcome of pregnancy following treatment of well-differentiated thyroid cancer with 131iodine.
    Balan KK; Critchley M
    Br J Obstet Gynaecol; 1992 Dec; 99(12):1021-2. PubMed ID: 1477008
    [No Abstract]   [Full Text] [Related]  

  • 77. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
    Scheffel RS; Zanella AB; Dora JM; Maia AL
    Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Advances in the selection and timing of postoperative radioiodine treatment in patients with differentiated thyroid carcinoma.
    Dai X; Ren X; Zhang J; Zheng Y; Wang Z; Cheng G
    Ann Nucl Med; 2024 Sep; 38(9):688-699. PubMed ID: 39044048
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dynamic risk assessment in patients with differentiated thyroid cancer.
    Abelleira E; Jerkovich F
    Rev Endocr Metab Disord; 2024 Feb; 25(1):79-93. PubMed ID: 38015344
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients.
    Al-Ibraheem A; Al-Rasheed U; Mashhadani N; Abdlkadir AS; Al-Adhami DA; Ruzzeh S; Istatieh F; Mansour A; Hamdan B; Kheetan R; Al-Shatti M; Mohamad I; Juweid ME; Abu Sheikha A; Al-Rabi K; Sykiotis GP; Kreissl MC; Ismael T; Sultan I; Abdel-Razeq H
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.